EP0973394A4 - NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI, AND VACCINE COMPOSITIONS CONTAINING SAME - Google Patents

NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI, AND VACCINE COMPOSITIONS CONTAINING SAME

Info

Publication number
EP0973394A4
EP0973394A4 EP97913847A EP97913847A EP0973394A4 EP 0973394 A4 EP0973394 A4 EP 0973394A4 EP 97913847 A EP97913847 A EP 97913847A EP 97913847 A EP97913847 A EP 97913847A EP 0973394 A4 EP0973394 A4 EP 0973394A4
Authority
EP
European Patent Office
Prior art keywords
helicobacter pylori
vaccine compositions
amino acid
nucleic acid
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97913847A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0973394A1 (en
Inventor
Douglas Smith
Richard A Alm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of EP0973394A1 publication Critical patent/EP0973394A1/en
Publication of EP0973394A4 publication Critical patent/EP0973394A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP97913847A 1996-10-28 1997-10-28 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI, AND VACCINE COMPOSITIONS CONTAINING SAME Withdrawn EP0973394A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US739150 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14
US891928 1997-07-14
PCT/US1997/019575 WO1998018323A1 (en) 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
US759739 2001-01-12

Publications (2)

Publication Number Publication Date
EP0973394A1 EP0973394A1 (en) 2000-01-26
EP0973394A4 true EP0973394A4 (en) 2005-03-30

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97913847A Withdrawn EP0973394A4 (en) 1996-10-28 1997-10-28 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI, AND VACCINE COMPOSITIONS CONTAINING SAME

Country Status (19)

Country Link
EP (1) EP0973394A4 (ar)
JP (1) JP2001504329A (ar)
KR (1) KR20000052831A (ar)
CN (1) CN1235513A (ar)
AR (1) AR009600A1 (ar)
AU (1) AU734052B2 (ar)
BR (1) BR9712587A (ar)
CA (1) CA2265523A1 (ar)
EE (1) EE9900176A (ar)
ID (1) ID22065A (ar)
IL (1) IL129397A0 (ar)
IS (1) IS5005A (ar)
NO (1) NO991995L (ar)
NZ (1) NZ334568A (ar)
PL (1) PL333169A1 (ar)
SA (1) SA98180918A (ar)
SK (1) SK34699A3 (ar)
TR (1) TR199900940T2 (ar)
WO (1) WO1998018323A1 (ar)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ314585A (en) * 1993-07-27 2000-08-25 Univ New South Wales Method of treating H. Pylori associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
DE19730425A1 (de) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heißhärtende wäschefeste Rohbau-Versiegelung
CA2336534A1 (en) * 1998-07-27 2000-02-10 Connaught Laboratories Limited Chlamydia antigens and corresponding dna fragments and uses thereof
SE9901548D0 (sv) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
EP1263942B1 (en) * 2000-03-08 2013-11-06 Novozymes A/S Variants with altered properties
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
JP6078865B2 (ja) * 2011-03-17 2017-02-15 国立大学法人三重大学 抗体の製造方法
US10828358B2 (en) * 2015-12-14 2020-11-10 Technische Universität München Helicobacter pylori vaccines
CN115724922B (zh) * 2022-07-19 2023-08-22 四川大学华西医院 一种幽门螺杆菌疫苗重组蛋白抗原TonB及其制备方法与应用
CN115581201A (zh) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 以茎段为外植体诱导的二倍体月季f1-61的植株再生方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016714A1 (en) * 1993-01-19 1994-08-04 Medicarb Ab The use of a composition for the treatment of infections caused by helicobacter pylori

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016714A1 (en) * 1993-01-19 1994-08-04 Medicarb Ab The use of a composition for the treatment of infections caused by helicobacter pylori

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 31 January 1997 (1997-01-31), AKOPYANTS, N.S. ET AL.: "Helicobacter pylori cosmid clone 36, complete sequence", XP002303939, Database accession no. AC000108 *
DATABASE UniProt 1 January 1998 (1998-01-01), TOMB, J.-F. ET AL.: "Outer membrane protein (Omp11)", Database accession no. O25218 *
JEAN-F. TOMB ET AL.: "The complete genome sequence of the gastric pathogen Helicobacter pylori", NATURE, vol. 389, 25 September 1997 (1997-09-25), pages 539 - 547, XP002303938 *
SCHMITT W ET AL: "GENETIC ANALYSIS OF THE HELICOBACTER PYLORI VACUOLATING CYTOTOXIN: STRUCTURAL SIMILARITIES WITH THE IGA PROTEASE TYPE OF EXPORTED PROTEIN", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, GB, vol. 12, no. 2, 1 April 1994 (1994-04-01), pages 307 - 319, XP000605827, ISSN: 0950-382X *
See also references of WO9818323A1 *

Also Published As

Publication number Publication date
AU5093398A (en) 1998-05-22
NO991995D0 (no) 1999-04-27
SK34699A3 (en) 2000-04-10
KR20000052831A (ko) 2000-08-25
TR199900940T2 (xx) 1999-09-21
AR009600A1 (es) 2000-04-26
SA98180918A (ar) 2005-12-03
EE9900176A (et) 1999-12-15
JP2001504329A (ja) 2001-04-03
ID22065A (id) 1999-08-26
IS5005A (is) 1999-03-18
BR9712587A (pt) 1999-10-26
EP0973394A1 (en) 2000-01-26
NZ334568A (en) 2000-04-28
WO1998018323A1 (en) 1998-05-07
CA2265523A1 (en) 1998-05-07
CN1235513A (zh) 1999-11-17
PL333169A1 (en) 1999-11-22
IL129397A0 (en) 2000-02-17
AU734052B2 (en) 2001-05-31
NO991995L (no) 1999-06-28

Similar Documents

Publication Publication Date Title
SK165197A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
HUP9901546A3 (en) Helicobacter pylori antigens and vaccine compositions
HUP0100267A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL129397A0 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL129746A0 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
AU1698699A (en) (helicobacter pylori) vaccine formulations
AU1055497A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
ZA979672B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof
HUP9903843A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP0000521A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL130291A0 (en) Compositions and methods for administering pneumococcal DNA
ZA9710971B (en) Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof.
ZA972715B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof.
HUP9900766A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
AU3066097A (en) Methods for sequencing large nucleic acid segments and compositions for large sequencing projects
EE9900566A (xx) Helicobacter pylori FlgE pol�peptiidi sisaldavad vaktsiinikoostised
ZA964869B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
EP1071325A4 (en) COMPOSITIONS AND METHODS FOR SPECIFIC VACCINATION OF THE ANTIGEN
GB2290710B (en) Protease from helicobacter pylori for use in vaccines/therapeutic compositions
AU8048698A (en) Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции
GB9610192D0 (en) DNA vaccine formulations
IL129027A0 (en) Novel nucleic acid and amino acid sequence

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990528

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: LT PAYMENT 19990528;LV PAYMENT 19990528;RO PAYMENT 19990528;SI PAYMENT 19990528

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ASTRAZENECA AB

RTI1 Title (correction)

Free format text: NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS THEREOF

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/68 B

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 39/106 B

Ipc: 7C 07K 19/00 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07K 14/205 B

Ipc: 7C 12N 15/31 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050215

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050504

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1024597

Country of ref document: HK